Brief: Timber Pharmaceuticals Announces Halt of Common Stock Trading
Nov 3 (Reuters) - Timber Pharmaceuticals Inc TMBR.A :
* TIMBER PHARMACEUTICALS ANNOUNCES HALT OF COMMON STOCK
TRADING
* TIMBER PHARMACEUTICALS-TRADING OF ITS SHARES OF COMMON
STOCK HAS
BEEN HALTED BY NYSE DUE TO LOW TRADING PRICE OF CO'S SHARES OF
COMMON STOCK ON NOV 1
* TIMBER PHARMACEUTICALS- SEEKING STOCKHOLDER APPROVAL TO
COMPLETE
REVERSE STOCK SPLIT IN ORDER TO REGAIN COMPLIANCE WITH NYSE'S
LISTING REQUIREMENTS
Source text for Eikon: ID:nGNX56Sw44
Further company coverage: TMBR.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing